Disclosed are a compound as shown in formula I, and a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, wherein each symbol is as defined in the claims. The compound as shown in formula I has a good inhibitory activity on ALK kinase, and can be used to prepare a drug for regulating ALK kinase activity or treating an ALK-associated disease, especially non-small cell lung cancer.